[go: up one dir, main page]

AR043966A1 - Derivados de 4- ( 2-feniloxifenil) - piperidina o 1,2,3,6 -tetrahidropiridina como inhibidores de la recaptacion de la serotonina - Google Patents

Derivados de 4- ( 2-feniloxifenil) - piperidina o 1,2,3,6 -tetrahidropiridina como inhibidores de la recaptacion de la serotonina

Info

Publication number
AR043966A1
AR043966A1 ARP040101132A ARP040101132A AR043966A1 AR 043966 A1 AR043966 A1 AR 043966A1 AR P040101132 A ARP040101132 A AR P040101132A AR P040101132 A ARP040101132 A AR P040101132A AR 043966 A1 AR043966 A1 AR 043966A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
hydrogen
ilo
independently selected
Prior art date
Application number
ARP040101132A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR043966(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR043966A1 publication Critical patent/AR043966A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Los compuestos son útiles para el tratamiento de trastornos afectivos, incluyendo la depresión, trastornos de ansiedad, incluyendo el trastorno de ansiedad general, trastorno de pánico y trastorno obsesivo compulsivo. Reivindicación 1: Un compuesto representado por la fórmula general (1), en la cual: la línea de puntos indica una unión simple o una unión doble; R1, R2, R3, R4, R5 se seleccionan independientemente de hidrógeno, halógeno, ciano, alqu(en/in)ilo C1-6, alqu(en/in)iloxi C1-6, alqu(en/in)ilsulfanilo C1-6, hidroxi, hidroxi-alqu(en/in)ilo C1-6, halo-alqu(en/in)ilo C1-6, halo-alqu(en/in)iloxi C1-6, o NRxRy en donde Rx y Ry se seleccionan independientemente de hidrógeno, alqu(en/in)ilo C1-6, ciano-alqu(en/in)ilo C1-6, cicloalqu(en)ilo C3-8, cicloalqu(en)il-(C3-8)-alqu(en/in)ilo (C1-6), o NRzRw-alqu(en/in)ilo C1-6, en donde Rz y Rw se seleccionan independientemente de hidrógeno, alqu(en/in)ilo C1-6, cicloalqu(en)ilo C3-8, o cicloalqu(en)il-(C3-8)-alqu(en/in)ilo (C1-6); o Rx y Ry junto con el nitrógeno al que están unidos forman un anillo de 3-7 miembros que opcionalmente contiene un heteroátomo adicional; o R2 y R3 forman juntos un heterociclo fusionado al anillo de fenilo seleccionado de la fórmula (2); R1, R4, R5 son como se definió anteriormente; R6, R7, R8, R9 se seleccionan independientemente de hidrógeno, halógeno, alqu(en/in)ilo C1-6, alqu(en/in)iloxi-C1-6, alqu(en/in)ilsulfanilo C1-6, hidroxi, hidroxi-alqu(en/in)ilo C1-6, halo-alqu(en/in)ilo C1-6, halo-alqu(en/in)iloxi C1-6, o NRxRy en donde Rx y Ry se seleccionan independientemente de hidrógeno, alqu(en/in)ilo C1-6, ciano-alqu(en/in)ilo C1-6, cicloalqu(en)ilo C3-8, cicloalqu(en)il-(C3-8)-alqu(en/in)ilo (C1-6), o NRzRw-alqu(en/in)ilo C1-6, en donde Rz y Rw se seleccionan independientemente de hidrógeno, alqu(en/in)ilo C1-6, cicloalqu(en)ilo C3-8, o cicloalqu(en)il-(C3-8)-alqu(en/in)ilo (C1-6); o Rx y Ry junto con el nitrógeno al que están unidos forman un anillo de 3-7 miembros que opcionalmente contiene un heteroátomo adicional; siempre al menos uno de R1, R2, R3, R4, R5, R6, R7, R8, y R9 sea diferente de hidrógeno; o una sal del mismo.
ARP040101132A 2003-04-04 2004-04-02 Derivados de 4- ( 2-feniloxifenil) - piperidina o 1,2,3,6 -tetrahidropiridina como inhibidores de la recaptacion de la serotonina AR043966A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300519 2003-04-04

Publications (1)

Publication Number Publication Date
AR043966A1 true AR043966A1 (es) 2005-08-17

Family

ID=36701494

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101132A AR043966A1 (es) 2003-04-04 2004-04-02 Derivados de 4- ( 2-feniloxifenil) - piperidina o 1,2,3,6 -tetrahidropiridina como inhibidores de la recaptacion de la serotonina

Country Status (8)

Country Link
KR (1) KR20050119682A (es)
CN (1) CN1767829A (es)
AR (1) AR043966A1 (es)
CL (1) CL2004000726A1 (es)
EA (1) EA009417B1 (es)
IS (1) IS7901A (es)
UA (1) UA81469C2 (es)
ZA (1) ZA200505031B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101613347B (zh) * 2008-06-23 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 胺类化合物及其医药用途
DK2358675T3 (da) * 2008-11-14 2013-01-14 Theravance Inc 4-[2-(2-Fluorphenoxymethyl)phenyl]piperidinforbindelser
CN104710345B (zh) * 2013-12-17 2017-09-05 江苏恩华药业股份有限公司 用于制备4‑（2‑（4‑甲基苯基硫基））苯基哌啶的化合物、其制备方法及应用
CN105348204B (zh) * 2015-11-18 2018-09-14 乳源瑶族自治县大众药品贸易有限公司 1-杂环基-2-(杂芳基硫基)苯衍生物及其使用方法和用途
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
GEP20043160B (en) * 1999-10-13 2004-01-26 Pfizer Products Inc Us Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors
UA81749C2 (uk) * 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну

Also Published As

Publication number Publication date
CN1767829A (zh) 2006-05-03
EA009417B1 (ru) 2007-12-28
CL2004000726A1 (es) 2005-05-20
EA200501580A1 (ru) 2006-04-28
ZA200505031B (en) 2006-09-27
IS7901A (is) 2005-06-20
UA81469C2 (en) 2008-01-10
KR20050119682A (ko) 2005-12-21

Similar Documents

Publication Publication Date Title
MY139750A (en) Cyclohexylamides as dopamine d3, d2 and 5ht1a antagonists
ES2613538T3 (es) Derivados de arilamida como bloqueadores de TTX-S
MX2009008465A (es) Nuevas 2-aminooxazolinas como ligandos de taar1.
ECSP099324A (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
AR054024A1 (es) Derivados de piridina -3- carboxamida como agonistas inversos de cb1
UA105185C2 (uk) Піроли
CO6241119A2 (es) Compuestos de pirido 2,3-d pirimidina-7-ona como inhibidores de pi3k-alfa para el tratamiento del cancer
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
AR061486A1 (es) Derivados de 2-pirazinacarboxamida
AR082886A1 (es) Compuestos y composiciones farmaceuticas que los contienen
ECSP099395A (es) Nuevos derivados de los ácidos amino-nicotínico y amino-isonicotínico
CO6160296A2 (es) Derivados de acido benzoazepin-oxi-acetico como agonistas de receptores activados por proliferador de peroxisona delta usados para incrementar la lipoproteina de alta densidad-colesterol-colesterol reducir la lipoproteina de baja densidad-colesterol
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
AR069480A1 (es) Derivados de 2-amino-pirimidina
PE20060583A1 (es) Tiazolil-dihidro-indazoles como inhibidores de pi3-quinasas
AR084913A1 (es) Derivados de aril-benzocicloalquil-amida
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
CO5650235A2 (es) Derivados de imidazol
ZA201002139B (en) New compounds as adenosine a1 receptor antagonists
CO6741199A2 (es) \"5-(fenil/piridinil-etinil)-2-piridina/ 2-pirimidina-caboxamidas como moduladores del receptor mglur5\"
CO6400145A2 (es) Derivados de 2-piridin-2-il pirazol-3(2h) -ona, su preparción y su aplicación terapeútica
AR043964A1 (es) Derivados de 4- ( 2-fenilsulfanil-fenil) 1,2,3,6-tetrahidropiridina como anhibidores de la recaptacion de serotonina
CO6300944A2 (es) Derivado de hidroxi-quinoxalin-carboxamida
AR057197A1 (es) Derivados de 1, 1-dioxo-tiomorfolinil-indolil-metanona
AR084606A1 (es) Derivados de biaril-amida

Legal Events

Date Code Title Description
FB Suspension of granting procedure